Oral contraceptives and endothelial function: Harm or benefit?

Journal of Hypertension

Volumn 21, Issue 12, 2003, Pages 2227-2230

  Buchner, Nikolaus J ^a   Rump, Lars C ^a,b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ETHINYLESTRADIOL PLUS GESTODENE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DRUG EFFECT; EDITORIAL; ENDOTHELIUM; ENDOTHELIUM INJURY; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPEREMIA; HYPERLIPIDEMIA; LIPID ANALYSIS; LONG TERM CARE; MENSTRUAL CYCLE; ORAL CONTRACEPTION; OXIDATIVE STRESS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; VASODILATATION;

EID: 1442299085     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200312000-00005     Document Type: Editorial

References (40)

1. Stadel BV. Oral contraceptives and cardiovascular disease. N Engl J Med 1981; 305:672-677.
2. Tarnis BC, van den Bosch MA, Kemmeren JM, Cats VM, Helmerhorst FM, Algra A, et al. Oral contraceptives and the risk of myocardial infarction. N Engl J Med 2001; 345:1787-1793.
3. Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Sydner TE, et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 2000; 343:522-529.
4. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/ progestin Replacement Study (HERS) Research Group. JAMA 1998; 280:605-613.
5. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, et al., for the Women's Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349: 523-534.
6. Virdis A, Pinto S, Versari D, Salvetti G, Bernini G, Fruzzetti F, et al. Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women. J Hypertens 2003; 21:2275-2280.
7. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101:948-954.
8. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101:1899-1906.
9. Luscher TF, Vanhoutte PM: The endothelium: modulator of vascular function. Boca Raton, FL: CRC Press; 1990.
10. Mattei P, Virdis A, Ghiadoni L, Taddei S, Salvetti A. Endothelial function in hypertension. J Nephrol 1997; 10:192-197.
11. Taddei S, Virdis A, Mattei P, Ghiadoni L, Fasolo CB, Sudano I, et al. Hypertension causes premature aging of endothelial function in humans. Hypertension 1997; 29:736-743.
12. Sanada M, Higashi Y, Nakagawa K, Kodama I, Tsuda M, Nagai N, et al. Comparison of forearm endothelial function between premenopausal and postmenopausal women with or without hypercholesterolemia. Maturitas 2003; 44:307-315.
13. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994; 24:471-476.
14. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo CB, et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 1995; 91:1981-1987.
15. Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996; 28:576-582.
16. Virdis A, Ghiadoni L, Pinto S, Lombardo M, Petraglia F, Gennazzani A, et al. Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women. Circulation 2000; 101:2258-2263.
17. 7 Virdis A, Ghiadoni L, Sudano I, Buralli S, Salvetti G, Taddei S, et al. Endothelial function in hypertension: role of gender. J Hypertens 2002; 20(suppl 2):S11-S16.
18. Shaul PW. Novel role of estrogen receptors in vascular endothelium. Semin Perinatol 2000; 24:70-74.
19. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340:1801-1811.
20. Barton M. Vascular effects of estrogens: rapid actions, novel mechanisms, and potential therapeutic implications. Zhongguo Yao Li Xue Bao 1999; 20:682-690.
21. Mendelsohn ME. Nongenomic, ER-mediated activation of endothelial nitric oxide synthase: how does it work? What does it mean? Circ Res 2000; 87:956-960.
22. Gerhard M, Walsh BW, Tawakol A, Haley EA, Creager SJ, Seely EW, et al. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation 1998; 98:1158-1163.
23. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO III. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994; 90:786-791.
24. Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994; 89:52-60.
25. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994; 121:936-941.
26. Herrington DM, Espeland MA, Crouse JR III, Robertson J, Riley WA, McBurnie MA, et al. Estrogen replacement and brachial artery flow-mediated vasodilation in older women. Arterioscler Thromb Vasc Biol 2001; 21:1955-1961.
27. Ganz P. Vasomotor and vascular effects of hormone replacement therapy. Am J Cardiol 2002; 90:11F-16F.
28. Sorensen KE, Dorup I, Hermann AP, Mosekilde L. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation 1998; 97:1234-1238.
29. Sorensen MB, Collins P, Ong PJL, Webb CM, Hayward CS, Asbury EA, et al. Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic response. Circulation 2002; 106:1646-1651.
30. Suzy YH, Pang B, Stojanovska L, Sudhir K, Komesaroff PA. Progesterone does not influence vascular function in postmenopausal women. J Hypertens 2003; 21:1145-1149.
31. Glusa E, Graser T, Wagner S, Oettel M. Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins. Maturitas 1997; 28:181-191.
32. Vogel RA. Coronary risk factors, endothelial function, and atherosclerosis: a review. Clin Cardiol 1997; 20:426-432.
33. Vogel RA, Corretti MC. Estrogens, progestins, and heart disease: can endothelial function divine the benefit? Circulation 1998; 97: 1223-1226.
34. John S, Jacobi J, Schlaich MP, Delles C, Schmieder RE. Effects of oral contraceptives on vascular endothelium in premenopausal women. Am J Obstet Gynecol 2000; 183:28-33.
35. No authors listed. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. The writing group for the PEPI trial. JAMA 1995; 273:199-208.
36. Merki-Feld GS, Rosselli M, Dubey RK, Jager AW, Keller PJ. Long-term-effects of combined oral contraceptives on markers of endothelial fonction and lipids in healthy premenopausal women. Contraception 2002;65:231-236.
37. Wilmink HW, Twickler MB, Banga JD, Dallinga-Thie GM, Eeltink H, Erkelens DW, et al. Effects of statin vs. fibrate on postprandial endothelial dysfunction: role of remnant-like particles. Cardiovasc Res 2002; 50:577-582.
38. Herrington DM. The HERS trial results: paradigms lost? Heart and Estrogen/progestin Replacement Study. Ann Intern Med 1999; 21: 463-466.
39. Cushman M, Meilahn EN, Psaty BM, Kuller LH, Dobs AS, Tracy RP. Hormone replacement therapy, inflammation, and the hemostasis in elderly women. Arterioscler Thromb Vasc Biol 1999; 19:893-899.
40. Ridker PM, Hennekens NR, Rifai N, Buring JE, Manson JE. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 1999; 100:713-716.